NEW YORK - Irish drug development and research company Icon PLC on Tuesday raised its 2008 profit and revenue expectations for the second time in three months, and its stock reached an all-time high.
| ICLR | 17.36 |
After reporting second-quarter results that surpassed Wall Street's estimates, Icon said it now expects a profit of $2.46 to $2.52 per share, with revenue ranging from $870 million to $890 million. It credited strong demand for its global services in revising its forecast.
On average, analysts reporting to Thomson Financial expect a profit of $2.44 per share on $852.7 million in revenue.
The company also said its board declared a 2-for-1 stock split. Holders of record Aug. 8 will receive one new ordinary share or American Depositary Share for each share held.
The news lifted Icon shares $4.68, or 6 percent, to $82.47, and earlier it reached an all-time high of $83.66.
In December, Icon forecast a 2008 profit of $2.27 to $2.36 per share on revenue between $750 million and $770 million. After reporting its first-quarter earnings in April, it raised those expectations to $2.35 to $2.45 per share on revenue of $840 million to $860 million.
Citigroup Inc. shares tumbled below $5 a share Thursday to their lowest level in...
As more Americans rely on charity amid worsening economic gloom, operators of fo...
Betty James, who co-founded the company that made the Slinky and beat the odds as a single mother in the late 1950s to become a successful execut...


Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Get your next web design project done with our los angeles web design team - Best web design with great price.